OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2
Manoj Kumar Yadav, Shaban Ahmad, Khalid Raza, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 5, pp. 1527-1539
Closed Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study
Shaban Ahmad, Khalid Raza
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1189-1202
Closed Access | Times Cited: 49

An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives
Shaban Ahmad, Khalid Raza
Journal of drug targeting (2024) Vol. 32, Iss. 6, pp. 635-646
Closed Access | Times Cited: 14

Artificial Intelligence in nanotechnology for treatment of diseases
Soroush Heydari, Niloofar Masoumi, Erfan Esmaeeli, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1247-1266
Closed Access | Times Cited: 9

Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7

In-silico analysis reveals Quinic acid as a multitargeted inhibitor against Cervical Cancer
Shaban Ahmad, Salwa Sayeed, Nagmi Bano, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9770-9786
Closed Access | Times Cited: 32

The Biomedical Applications of Artificial Intelligence: An Overview of Decades of Research
Sweet Naskar, Suraj Sharma, Ketousetuo Kuotsu, et al.
Journal of drug targeting (2025), pp. 1-85
Closed Access

Lucidin from Rubia cordifolia Outperforms FDA-Approved Lapatinib as a Potential Multitargeted Candidate for Breast Cancer Signalling Proteins
Akram Ahmed Aloqbi, Hadil Alahdal, Amany I. Alqosaibi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 68-68
Open Access

PHYTOCHEMICAL CHARACTERIZATION, IN VITRO AND IN SILICO STUDIES ON THERAPEUTIC POTENTIAL OF EDIBLE AND WILD MUSHROOMS
JEYA PREETHI S, P. Sharmila, K Sangeetha, et al.
Asian Journal of Pharmaceutical and Clinical Research (2025), pp. 68-80
Open Access

Repositioning of Furin inhibitors as potential drugs against SARS-CoV-2 through computational approaches
Asmae Saih, Soukayna Baammi, Hicham Charoute, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-15
Closed Access

Investigating the Inhibitory Effects of Paliperidone on RAGEs: Docking, DFT, MD Simulations, MMPBSA, MTT, Apoptosis, and Immunoblotting Studies
Akash Pratap Singh, Shaban Ahmad, Anamika Roy, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1060-1060
Open Access

Blood transcriptomics identifies FEZ1 as a potential biomarker for inflammatory bowel disease
Arman Mokaram Doust Delkhah
Computers in Biology and Medicine (2025) Vol. 187, pp. 109742-109742
Closed Access

Evaluating the polypharmacological potency of FEDPN from ChEMBL BioAssays against lung cancer EGFR, ALK, TrkA and KRAS proteins
Shaban Ahmad, Nagmi Bano, Khalid Raza
International Journal of Biological Macromolecules (2025), pp. 141703-141703
Closed Access

An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD)
Dwipanjan Sanyal, Suharto Banerjee, Aritra Bej, et al.
International Journal of Biological Macromolecules (2022) Vol. 217, pp. 492-505
Open Access | Times Cited: 17

Delineated 3-1-BenCarMethInYlPro-Phosphonic Acid’s Adroit Activity against Lung Cancer through Multitargeted Docking, MM\GBSA, QM-DFT and Multiscale Simulations
Mohammed Ageeli Hakami, Ali Hazazi, Fawaz Albloui, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 592-592
Open Access | Times Cited: 2

Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor
Hassan H. Almasoudi, Mutaib M. Mashraqi, Saleh Alshamrani, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 208-208
Open Access | Times Cited: 2

Computational Intelligence Methods for Biomarkers Discovery in Autoimmune Diseases: Case Studies
Nagmi Bano, Iqra Sajid, Syed Akramah Ahmad Faizi, et al.
Studies in computational intelligence (2024), pp. 303-323
Closed Access | Times Cited: 2

Synthesis, structural elucidation, and antibacterial activities of novel copper(II), cobalt(II), and nickel(II) complexes with a bidentate Schiff base ligand against pathogenic bacteria
Nitu Singh, Pradeep Kumar, Shaban Ahmad, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139874-139874
Closed Access | Times Cited: 2

Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study
Saad Alghamdi, Hanadi M. Baeissa, Mohammad Azhar Kamal, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 16, pp. 8268-8280
Closed Access | Times Cited: 7

An in vivo and in silico evaluation of the hepatoprotective potential of Gynura procumbens: A promising agent for combating hepatotoxicity
Tanzia Islam Tithi, Md. Rafat Tahsin, Juhaer Anjum, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0291125-e0291125
Open Access | Times Cited: 7

Harnessing Machine Learning Potential for Personalised Drug Design and Overcoming Drug Resistance
Mohammed Ageeli Hakami
Journal of drug targeting (2024) Vol. 32, Iss. 8, pp. 918-930
Closed Access | Times Cited: 2

Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study
Hassan H. Almasoudi, Mohammed Ageeli Hakami, Abdulfattah Yahya M. Alhazmi, et al.
Medical Oncology (2023) Vol. 40, Iss. 8
Closed Access | Times Cited: 5

Page 1 - Next Page

Scroll to top